|
测量指标：
Outcomes：
|
|
指标中文名：
|
湿疹患者自我评价POEM评分
|
指标类型：
|
次要指标
|
|
Outcome：
|
Patient Eczema Self-Assessment Score(POEM Score)
|
Type：
|
Secondary indicator
|
|
测量时间点：
|
第0天、14天、28天
|
测量方法：
|
POEM评分量表由7个问题组成，每个问题的答案反映了湿疹症状的严重程度，每个问题的答案根据频率或严重程度进行评分（0至4分）。评分总和即为 POEM 评分，总分范围为0至28分，得分越高表示湿疹的症状越严重，影响患者的生活质量越大。
|
|
Measure time point of outcome：
|
Day 0, Day 14, Day 28
|
Measure method：
|
The POEM scoring scale consists of 7 questions, each reflecting the severity of eczema symptoms. The answers to each question are scored based on frequency or severity (from 0 to 4 points). The total score is the sum of the points, with a range from 0 to 28. The higher the score, the more severe the eczema symptoms and the greater the impact on the patient's quality of life.
|
|
指标中文名：
|
皮肤病生活质量DLQI评分
|
指标类型：
|
次要指标
|
|
Outcome：
|
Dermatology Life Quality Index (DLQI) Score
|
Type：
|
Secondary indicator
|
|
测量时间点：
|
第0天、14天、28天
|
测量方法：
|
DLQI是评估皮肤病患者生活质量的一个工具，涵盖了与皮肤病相关的症状和日常生活的影响。该量表由10个问题组成，涉及皮肤病对患者生活的各个方面，如情绪、工作、社交活动等。每个问题的评分范围是0至3，分数越高表示皮肤病对生活质量的影响越大。最终得分是所有问题得分的总和，得分越高，患者生活质量受损的程度越严重。
|
|
Measure time point of outcome：
|
Day 0, Day 14, Day 28
|
Measure method：
|
DLQI is a tool used to assess the quality of life of patients with dermatological conditions, covering the symptoms related to the skin condition and its impact on daily life. The scale consists of 10 questions that address various aspects of life affected by the skin condition, such as emotions, work, and social activities. Each question is scored from 0 to 3, with higher scores indicating a greater impact of the skin condition on quality of lif
|
|
指标中文名：
|
皮疹面积
|
指标类型：
|
次要指标
|
|
Outcome：
|
Rash area
|
Type：
|
Secondary indicator
|
|
测量时间点：
|
第0天、14天、28天
|
测量方法：
|
本次实验仅观察手部皮损，故选择单个较典型的皮损为靶皮损，分别于治疗前和实验结束后测量其面积，按测量得出的面积大小，计算缩小的百分数作为比较。
|
|
Measure time point of outcome：
|
Day 0, Day 14, Day 28
|
Measure method：
|
This experiment only observed hand lesions, so a single, typical lesion was selected as the target lesion. The area of the lesion was measured before treatment and after the experiment ended. Based on the measured area, the percentage of reduction was calculated for comparison.
|
|
指标中文名：
|
研究者整体评分IGA评分
|
指标类型：
|
次要指标
|
|
Outcome：
|
IGA score
|
Type：
|
Secondary indicator
|
|
测量时间点：
|
第0天、14天、28天
|
测量方法：
|
IGA评分是一种由研究者或临床医生基于患者的皮肤状况进行评估的方法。它通常用于湿疹或其他皮肤病的临床试验中，评估疾病的严重程度。IGA评分通过观察皮肤病的表现（如红肿、渗出、厚度等）来进行评分。评分通常为五分制。
|
|
Measure time point of outcome：
|
Day 0, Day 14, Day 28
|
Measure method：
|
IGA Score is an assessment method used by researchers or clinicians based on the patient's skin condition. It is commonly used in clinical trials for eczema or other skin diseases to assess the severity of the disease. The IGA score is determined by observing the presentation of the skin disease (such as redness, exudation, thickness, etc.). The scoring is typically a 5-point scale.
|
|
指标中文名：
|
瘙痒严重程度评分
|
指标类型：
|
主要指标
|
|
Outcome：
|
NRS score
|
Type：
|
Primary indicator
|
|
测量时间点：
|
第0天、14天、28天
|
测量方法：
|
NRS 由一条类似于视觉模拟量表（visual analogue scale，VAS） 线段的水平线段组成，通常也以“没有瘙痒”和“极度瘙痒”或“所经 历过的最剧烈的瘙痒”作为起始点与终点的锚定语，并分别以“0”和 “10” 标记， 0 分代表无瘙痒， 10 分代表能想象到的最严重的瘙痒， 得分越高， 瘙痒程度越重。
|
|
Measure time point of outcome：
|
Day 0, Day 14, Day 28
|
Measure method：
|
The NRS consists of a horizontal line segment similar to a visual analogue scale (VAS), typically anchored with phrases like "no itching" and "extreme itching" or "the most severe itching ever experienced" at the start and end points, respectively, and marked as "0" and "10". A score of 0 represents no itching, and a score of 10 represents the most intense itching imaginable. The higher the score, the greater the severity of the itch.
|
|
指标中文名：
|
手部湿疹严重指数（HECSI）评分
|
指标类型：
|
主要指标
|
|
Outcome：
|
HECSI score
|
Type：
|
Primary indicator
|
|
测量时间点：
|
第0天、14天、28天
|
测量方法：
|
将每只手分为指尖、手指（指尖以外）、手掌、手背及腕部，无皮损改变、轻度、中度、重度分别记0、1、2、3分。皮损包括红斑、丘疹、水疱、皲裂、鳞屑、水肿，每个部位总分为各皮损评分之和。
|
|
Measure time point of outcome：
|
Day 0, Day 14, Day 28
|
Measure method：
|
Each hand is divided into the following areas: fingertip, fingers (excluding fingertips), palm, dorsum of the hand, and wrist. For each area, the severity of lesions is scored as 0 (no change), 1 (mild), 2 (moderate), or 3 (severe). Lesions include erythema, papules, vesicles, fissures, scales, and edema. The total score for each area is the sum of the scores for each type of lesion.
|
|
